Latest On Acorda Therapeutics, Inc (ACOR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 05:46 EST | News | Acorda Therapeutics GAAP EPS of -$0.69 beats by $0.42, revenue of $22.25M misses by $8.76M | N/A |  |
| 2023-05-12 05:45 EST | News | Acorda Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation | N/A | |
| 2023-05-12 05:45 EST | News | Acorda Therapeutics, Inc. (ACOR) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-11 01:30 EST | News | Acorda Therapeutics Q1 Earnings Preview | N/A | |
| 2023-05-10 12:16 EST | News | Acorda Therapeutics down 8%, makes $6.2M interest payment in cash | N/A | |
| 2023-05-08 20:31 EST | News | Acorda Therapeutics and Hangzhou Chance Pharmaceuticals join forces to introduce Parkinson's disease therapy in China; shares surge by 7% | N/A | |
| 2023-03-10 19:30 EST | News | Acorda Therapeutics, Inc. (ACOR) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-10 04:16 EST | News | Acorda stock dips as Q4 revenue slumps ~15% | N/A | |
| 2023-03-09 12:31 EST | News | Acorda Therapeutics GAAP EPS of $0.57, revenue of $31.47M | N/A | |
| 2023-01-05 19:30 EST | News | Acorda strikes new global supply deal with Catalent for its inhalation powder Inbrija | N/A | |
| 2022-12-22 09:46 EST | News | Acorda projects positive adj. EBITDA in revised 2022 guidance | N/A | |
| 2022-12-21 17:19 EST | News | Acorda Therapeutics gets Nasdaq delisting notice, plans to appeal decision | N/A | |
| 2022-11-01 21:46 EST | News | Acorda Therapeutics GAAP EPS of -$0.57, revenue of $33.51M | N/A | |
| 2022-11-01 21:45 EST | News | Acorda Therapeutics, Inc. (ACOR) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-10-27 21:02 EST | News | Acorda gains on plans to become cashflow positive in 2023 | N/A | |
| 2022-10-17 11:17 EST | News | Acorda wins $16.5M in Ampyra arbitration case with Alkermes | N/A | |
| 2022-10-10 08:46 EST | News | Acorda stock rise 11% as proposal to increase shares withdrawn; reverse split still on vote | N/A | |
| 2022-08-29 08:15 EST | News | Acorda inks license deal with Asieris for pre-clinical drug | N/A | |
| 2022-08-19 09:46 EST | News | Acorda Therapeutics announces resignation of COO | N/A | |
| 2022-08-07 19:00 EST | News | Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 22:46 EST | News | Acorda Therapeutics Non-GAAP EPS of -$3.15, revenue of $31.05M | N/A | |
| 2022-06-16 14:15 EST | News | Nano-cap biotech Acorda surges 50% on drug launch in Germany | N/A | |
| 2022-05-13 06:31 EST | News | Acorda Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-12 11:47 EST | News | Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-11 18:00 EST | News | Acorda Therapeutics Non-GAAP EPS of -$1.66, revenue of $22.53M | N/A | |
| 2022-05-11 18:00 EST | News | Acorda partners with Biopas to sell Parkinson's disease therapy in Latin America | N/A | |
| 2022-03-10 11:31 EST | News | Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-09 19:15 EST | News | Acorda Therapeutics Non-GAAP EPS of -$0.67, revenue of $36.07M beats by $5.06M | N/A | |
| 2022-03-09 02:30 EST | News | Acorda Therapeutics Q4 Earnings Preview | N/A | |
| 2021-11-10 01:31 EST | News | Acorda Therapeutics EPS beats by $0.13, beats on revenue | N/A | |
| 2021-11-10 01:30 EST | News | Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-09 02:46 EST | News | Acorda Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-10-04 22:16 EST | News | Acorda Therapeutics: Managing The Transition | N/A | |
| 2021-08-09 22:16 EST | News | Acorda Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-09 02:46 EST | News | Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-05 21:02 EST | News | Acorda Therapeutics EPS misses by $0.20, beats on revenue | N/A | |
| 2021-07-24 07:15 EST | News | Acorda Therapeutics Continues To Maneuver For A Turnaround | N/A | |
| 2021-07-23 14:16 EST | News | Xenetic Biosciences, Medigus leads healthcare gainers; ImmunoPrecise Antibodies, Adverum Biotechnologies among major losers | N/A | |
| 2021-07-22 18:17 EST | News | Acorda shares surge 27% on INBRIJA distribution and supply deal | N/A | |
| 2021-07-20 17:46 EST | News | Acorda Therapeutics to repay convertible senior notes | N/A | |
| 2021-07-20 17:46 EST | News | CureVac downgraded following COVID vaccine data, Regeneron COVID cocktail a boon, and more in analyst action | N/A | |
| 2021-05-07 23:02 EST | News | Acorda Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-05-07 02:46 EST | News | Acorda Therapeutics EPS beats by $0.08, beats on revenue | N/A | |
| 2021-04-30 05:01 EST | News | Acorda Therapeutics: Buying Before The Coast Is Clear | N/A | |
| 2021-03-09 07:01 EST | Analyst Rating | The Analyst Target Price has increased from $17 to $17.5. | Buy | |
| 2021-03-06 07:01 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-05 14:03 EST | News | Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-05 14:01 EST | News | SIFY, WTI, OPEN and EVFM among notable midday movers | N/A | |
| 2021-03-05 14:00 EST | News | Acorda Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-03-05 11:01 EST | Earnings Estimate | An EPS average of -$5.95 is estimated for the 2022 year. | Sell | |
About Acorda Therapeutics, Inc (ACOR):
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops Inbrija for the treatment of OFF periods in Parkinson's disease and ARCUS product for the treatment of acute migraine. Further, it develops rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa that is in Phase Ib clinical trial for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York.
General
- Name Acorda Therapeutics, Inc
- Symbol ACOR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Last Split Factor1:6
- Last Split Date2021-01-04
- Fiscal Year EndDecember
- IPO Date2006-02-10
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.acorda.com
View More
Valuation
- Trailing PE 1.11
- Price/Sales (Trailing 12 Mt.) 0.32
- Price/Book (Most Recent Quarter) 0.24
- Enterprise Value Revenue 1.66
- Enterprise Value EBITDA 2.21
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$7.54
- Next Year EPS Estimate -$4.59
- Next Quarter EPS Estimate -$2.37
- Profit Margin -65%
- Operating Margin -57%
- Return on Assets -8%
- Return on Equity -36%
- Revenue 152.97 million
- Earnings Per Share $6.13
- Revenue Per Share $18.92
- Gross Profit 96.79 million
- Quarterly Earnings Growth -24.4%
View More
Highlights
- Market Capitalization 52 million
- EBITDA -16363000
- PE Ratio -7.36
- PEG Ratio 0.51
- Analyst Target Price $17.5
- Book Value Per Share $25.13
View More
Share Statistics
- Shares Outstanding 9.49 million
- Shares Float 8.46 million
- % Held by Insiders 169%
- % Held by Institutions 49.59%
- Shares Short 761102
- Shares Short Prior Month 750157
- Short Ratio 2.12
- Short % of Float 9%
- Short % of Shares Outstanding 8%
View More
Technicals
- Beta 0.56
- 52 Week High $8.66
- 52 Week Low $2.53
- 50 Day Moving Average 6.55
- 200 Day Moving Average 5
View More
Dividends
- Dividend Date 2021-01-04
- ExDividend Date N/A
- Dividend Yield 0%
View More
Acorda Therapeutics, Inc (ACOR) Dividend Calendar:
ACOR's last dividend payment was made to shareholders on January 4, 2021.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Acorda Therapeutics, Inc (ACOR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-04 | $N/A | -$2.50 | -$1.48 | -68.92% |
| 2020-09-30 | 2020-11-03 | $N/A | -$1.38 | -$1.78 | 22.47% |
| 2020-06-30 | 2020-08-04 | $N/A | -$2.10 | -$2.40 | 12.49% |
| 2020-03-31 | 2020-05-05 | $28.1 million | -$3.06 | -$2.49 | -22.89% |
| 2019-12-31 | 2020-02-13 | $50.5 million | -$0.90 | -$2.48 | 63.71% |
| 2019-09-30 | 2019-11-04 | $47.72 million | -$2.76 | -$3.08 | 10.29% |
| 2019-06-30 | 2019-08-01 | $50.05 million | -$3.30 | -$6.35 | 47.99% |
| 2019-03-31 | 2019-05-02 | $44.14 million | -$3.36 | -$5.84 | 42.47% |
| 2018-12-31 | 2019-02-14 | $69.15 million | $2.70 | -$5.08 | 153.15% |
| 2018-09-30 | 2018-10-31 | $142.81 million | $1.02 | $0.50 | 103.39% |
| 2018-06-30 | 2018-08-02 | $153.3 million | $8.40 | $4.29 | 95.95% |
| 2018-03-31 | 2018-05-02 | $106.17 million | $0.84 | $2.84 | -70.47% |
| 2017-12-31 | 2018-02-15 | $188.4 million | $3.66 | $6.30 | -41.92% |
| 2017-09-30 | 2017-10-31 | $141.07 million | $2.58 | $3.92 | -34.12% |
| 2017-06-30 | 2017-07-27 | $139.44 million | $1.74 | $2.56 | -32.03% |
| 2017-03-31 | 2017-04-27 | $119.39 million | -$0.48 | $0.12 | -484.62% |
| 2016-12-31 | 2017-02-14 | $140.63 million | $0.30 | $0.74 | -59.63% |
| 2016-09-30 | 2016-10-27 | $135.61 million | $0.54 | $0.50 | 8% |
| 2016-06-30 | 2016-07-28 | $127.46 million | $0.42 | $1.41 | -70.21% |
| 2016-03-31 | 2016-04-28 | $115.9 million | $0.42 | $0.76 | -44.74% |
| 2015-12-31 | 2016-02-11 | $130.9 million | $0.28 | $0.26 | 9.8% |
| 2015-09-30 | 2015-10-22 | $148.2 million | $0.31 | $0.15 | 106.67% |
| 2015-06-30 | 2015-07-30 | $113.71 million | $0.31 | $0.17 | 82.35% |
| 2015-03-31 | 2015-04-30 | $99.85 million | $0.15 | $0.14 | 7.14% |
| 2014-12-31 | 2015-02-12 | $117.87 million | $0.22 | $0.14 | 57.14% |
| 2014-09-30 | 2014-10-30 | $105.96 million | $0.28 | $0.05 | 460% |
| 2014-06-30 | 2014-07-31 | $97.13 million | $0.11 | $0.15 | -26.67% |
| 2014-03-31 | 2014-05-06 | $80.52 million | $0.02 | $0.09 | -77.78% |
| 2013-12-31 | 2014-02-13 | $92.59 million | $0.15 | $0.15 | 0% |
| 2013-09-30 | 2013-10-31 | $84.92 million | $0.18 | $0.13 | 38.46% |
| 2013-06-30 | 2013-08-01 | $87.05 million | $0.09 | $0.09 | 0% |
| 2013-03-31 | 2013-05-02 | $71.87 million | -$0.03 | $0.13 | -123.08% |
| 2012-12-31 | 2013-02-13 | $81.47 million | $0.01 | $0.15 | -93.33% |
| 2012-09-30 | 2012-10-31 | $77.44 million | $0.24 | $0.10 | 140% |
| 2012-06-30 | 2012-07-31 | $75.66 million | $0.11 | $0.12 | -8.33% |
| 2012-03-31 | 2012-05-03 | $71.25 million | $0.25 | $0.18 | 38.89% |
| 2011-12-31 | 2012-02-16 | $36.68 million | $0.32 | $0.18 | 77.78% |
| 2011-09-30 | 2011-11-04 | $93.03 million | $0.90 | $0.73 | 23.29% |
| 2011-06-30 | 2011-08-01 | $65.28 million | $0.07 | $0.12 | -41.67% |
| 2011-03-31 | 2011-05-05 | $61.29 million | -$0.02 | $0.17 | -111.76% |
| 2010-12-31 | 2011-02-17 | $66.8 million | $0.09 | $0.17 | -47.06% |
| 2010-09-30 | 2010-11-01 | $63.62 million | $0.31 | -$0.12 | 358.33% |
| 2010-06-30 | 2010-08-03 | $42.84 million | -$0.18 | -$0.46 | 60.87% |
| 2010-03-31 | 2010-04-30 | $17.75 million | -$0.56 | -$0.56 | 0% |
| 2009-12-31 | 2010-02-23 | $14.44 million | -$0.59 | -$0.59 | 0% |
| 2009-09-30 | 2009-11-03 | $15.21 million | -$0.51 | -$0.59 | 13.56% |
| 2009-06-30 | 2009-08-04 | $12.55 million | -$0.62 | -$0.55 | -12.73% |
| 2009-03-31 | 2009-05-06 | $12.47 million | -$0.50 | -$0.55 | 9.09% |
| 2008-12-31 | 2009-02-24 | $12.46 million | -$0.54 | -$0.52 | -3.85% |
| 2008-09-30 | 2008-11-04 | $12.47 million | -$0.53 | -$0.48 | -10.42% |
| 2008-06-30 | 2008-08-05 | $11.39 million | -$0.58 | -$0.48 | -20.83% |
| 2008-03-31 | 2008-05-05 | $11.51 million | -$0.54 | -$0.43 | -25.58% |
| 2007-12-31 | 2008-02-11 | $11.22 million | -$0.48 | -$0.31 | -54.84% |
| 2007-09-30 | 2007-11-06 | $10.46 million | -$0.30 | -$0.28 | -7.14% |
| 2007-06-30 | 2007-08-07 | $9.49 million | -$0.33 | -$0.32 | -3.13% |
| 2007-03-31 | 2007-05-10 | $8.32 million | -$0.32 | -$0.33 | 3.03% |
| 2006-12-31 | 2007-02-20 | $7.72 million | -$0.30 | -$0.36 | 16.67% |
| 2006-09-30 | 2006-11-02 | $6.23 million | -$0.37 | -$0.37 | 0% |
| 2006-06-30 | 2006-08-03 | $5.37 million | -$0.15 | -$0.39 | 61.54% |
| 2006-03-31 | 2006-05-05 | $3.8 million | -$4.05 | -$0.58 | -598.28% |
Acorda Therapeutics, Inc (ACOR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Acorda Therapeutics, Inc (ACOR) Chart:
Acorda Therapeutics, Inc (ACOR) News:
Below you will find a list of latest news for Acorda Therapeutics, Inc (ACOR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Acorda Therapeutics, Inc (ACOR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest ACOR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:58 PM EST | 100 | $0.3607 |
| Jun 13, 2022 7:58 PM EST | 100 | $0.3607 |
| Jun 13, 2022 7:59 PM EST | 100 | $0.3607 |
| Jun 13, 2022 7:59 PM EST | 54 | $0.3607 |
| Jun 13, 2022 7:59 PM EST | 46 | $0.3607 |
Acorda Therapeutics, Inc (ACOR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1008848/000156459020030911/0001564590-20-030911-index.htm |
| 2020-01-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1008848/000000000020000531/0000000000-20-000531-index.htm |
| 2020-06-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1008848/000000000020005882/0000000000-20-005882-index.htm |
| 2020-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1008848/000000000020008741/0000000000-20-008741-index.htm |
| 2020-09-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1008848/000000000020008806/0000000000-20-008806-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000009375119000143/0000093751-19-000143-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000009375120000481/0000093751-20-000481-index.htm |
| 2019-01-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000021545719000946/0000215457-19-000946-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000031506619000832/0000315066-19-000832-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000031506620000778/0000315066-20-000778-index.htm |
| 2020-06-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000031506620001595/0000315066-20-001595-index.htm |
| 2020-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000031506620001687/0000315066-20-001687-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000083423720001574/0000834237-20-001574-index.htm |
| 2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000083423720009585/0000834237-20-009585-index.htm |
| 2020-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000083423720009941/0000834237-20-009941-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000089109219001697/0000891092-19-001697-index.htm |
| 2019-11-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000089109219012325/0000891092-19-012325-index.htm |
| 2020-01-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000089914020000005/0000899140-20-000005-index.htm |
| 2018-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924318030850/0000899243-18-030850-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031240/0000899243-18-031240-index.htm |
| 2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031410/0000899243-18-031410-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031586/0000899243-18-031586-index.htm |
| 2018-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031705/0000899243-18-031705-index.htm |
| 2018-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031937/0000899243-18-031937-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000110/0000899243-19-000110-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000662/0000899243-19-000662-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000841/0000899243-19-000841-index.htm |
| 2019-01-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001035/0000899243-19-001035-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001225/0000899243-19-001225-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001353/0000899243-19-001353-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001594/0000899243-19-001594-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001870/0000899243-19-001870-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319002030/0000899243-19-002030-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000089924319002315/0000899243-19-002315-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000093247119004819/0000932471-19-004819-index.htm |
| 2018-12-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1008848/000101143818000208/0001011438-18-000208-index.htm |
| 2019-01-08 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1008848/000101143819000008/0001011438-19-000008-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000103738920000018/0001037389-20-000018-index.htm |
| 2020-01-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000108514620000095/0001085146-20-000095-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000110465920017254/0001104659-20-017254-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000110465920021677/0001104659-20-021677-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000114420419008389/0001144204-19-008389-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000119312519323087/0001193125-19-323087-index.htm |
| 2020-01-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000119312520007844/0001193125-20-007844-index.htm |
| 2020-09-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1008848/000119312520243985/0001193125-20-243985-index.htm |
| 2020-09-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1008848/000119312520247212/0001193125-20-247212-index.htm |
| 2020-09-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1008848/000119312520247216/0001193125-20-247216-index.htm |
| 2018-12-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118063965/0001209191-18-063965-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064139/0001209191-18-064139-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064140/0001209191-18-064140-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064141/0001209191-18-064141-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064142/0001209191-18-064142-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064143/0001209191-18-064143-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064144/0001209191-18-064144-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012956/0001209191-19-012956-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012966/0001209191-19-012966-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012973/0001209191-19-012973-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012975/0001209191-19-012975-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012980/0001209191-19-012980-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018786/0001209191-19-018786-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018789/0001209191-19-018789-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018791/0001209191-19-018791-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018793/0001209191-19-018793-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018794/0001209191-19-018794-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018797/0001209191-19-018797-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018799/0001209191-19-018799-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038362/0001209191-19-038362-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038363/0001209191-19-038363-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038364/0001209191-19-038364-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038365/0001209191-19-038365-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038366/0001209191-19-038366-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038367/0001209191-19-038367-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119038368/0001209191-19-038368-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119055900/0001209191-19-055900-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119055902/0001209191-19-055902-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119055904/0001209191-19-055904-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119055907/0001209191-19-055907-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119055909/0001209191-19-055909-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058936/0001209191-19-058936-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058937/0001209191-19-058937-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058938/0001209191-19-058938-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058939/0001209191-19-058939-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037298/0001209191-20-037298-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037301/0001209191-20-037301-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037303/0001209191-20-037303-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037307/0001209191-20-037307-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037309/0001209191-20-037309-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037312/0001209191-20-037312-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120037475/0001209191-20-037475-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051237/0001209191-20-051237-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051239/0001209191-20-051239-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051240/0001209191-20-051240-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051241/0001209191-20-051241-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000125889719000843/0001258897-19-000843-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1008848/000125889720000749/0001258897-20-000749-index.htm |
| 2019-01-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1008848/000131586319000080/0001315863-19-000080-index.htm |
| 2018-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459018031371/0001564590-18-031371-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019000284/0001564590-19-000284-index.htm |
| 2019-01-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019000744/0001564590-19-000744-index.htm |
| 2019-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019001172/0001564590-19-001172-index.htm |
| 2019-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019001762/0001564590-19-001762-index.htm |
| 2019-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019002991/0001564590-19-002991-index.htm |
| 2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1008848/000156459019004986/0001564590-19-004986-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019005446/0001564590-19-005446-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019006886/0001564590-19-006886-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1008848/000156459019013385/0001564590-19-013385-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019015013/0001564590-19-015013-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459019016616/0001564590-19-016616-index.htm |
| 2019-05-31 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019021249/0001564590-19-021249-index.htm |
| 2019-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019022903/0001564590-19-022903-index.htm |
| 2019-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019026258/0001564590-19-026258-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019027936/0001564590-19-027936-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459019029654/0001564590-19-029654-index.htm |
| 2019-08-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1008848/000156459019031247/0001564590-19-031247-index.htm |
| 2019-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019035241/0001564590-19-035241-index.htm |
| 2019-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019036439/0001564590-19-036439-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019036579/0001564590-19-036579-index.htm |
| 2019-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019037557/0001564590-19-037557-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019039772/0001564590-19-039772-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459019041866/0001564590-19-041866-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019042549/0001564590-19-042549-index.htm |
| 2019-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459019044612/0001564590-19-044612-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020001135/0001564590-20-001135-index.htm |
| 2020-01-15 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1008848/000156459020001171/0001564590-20-001171-index.htm |
| 2020-01-22 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1008848/000156459020001636/0001564590-20-001636-index.htm |
| 2020-01-24 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020001896/0001564590-20-001896-index.htm |
| 2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020004477/0001564590-20-004477-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/0001564590-20-007789-index.htm |
| 2020-04-03 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1008848/000156459020015311/0001564590-20-015311-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1008848/000156459020019298/0001564590-20-019298-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020021240/0001564590-20-021240-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020023661/0001564590-20-023661-index.htm |
| 2020-05-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020026741/0001564590-20-026741-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020029426/0001564590-20-029426-index.htm |
| 2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020030803/0001564590-20-030803-index.htm |
| 2020-06-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020030806/0001564590-20-030806-index.htm |
| 2020-06-26 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1008848/000156459020030812/0001564590-20-030812-index.htm |
| 2020-06-29 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1008848/000156459020030911/0001564590-20-030911-index.htm |
| 2020-07-01 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1008848/000156459020031444/0001564590-20-031444-index.htm |
| 2020-07-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1008848/000156459020031755/0001564590-20-031755-index.htm |
| 2020-07-06 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020031850/0001564590-20-031850-index.htm |
| 2020-07-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020032349/0001564590-20-032349-index.htm |
| 2020-07-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020032351/0001564590-20-032351-index.htm |
| 2020-07-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020032923/0001564590-20-032923-index.htm |
| 2020-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020033398/0001564590-20-033398-index.htm |
| 2020-07-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020033614/0001564590-20-033614-index.htm |
| 2020-07-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020033615/0001564590-20-033615-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020035102/0001564590-20-035102-index.htm |
| 2020-07-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020035110/0001564590-20-035110-index.htm |
| 2020-08-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020035535/0001564590-20-035535-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020036106/0001564590-20-036106-index.htm |
| 2020-08-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020036177/0001564590-20-036177-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020038393/0001564590-20-038393-index.htm |
| 2020-08-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020038901/0001564590-20-038901-index.htm |
| 2020-08-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020040439/0001564590-20-040439-index.htm |
| 2020-08-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020040441/0001564590-20-040441-index.htm |
| 2020-08-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1008848/000156459020040802/0001564590-20-040802-index.htm |
| 2020-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020041596/0001564590-20-041596-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020042021/0001564590-20-042021-index.htm |
| 2020-09-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1008848/000156459020043201/0001564590-20-043201-index.htm |
| 2020-09-17 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020043851/0001564590-20-043851-index.htm |
| 2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020045827/0001564590-20-045827-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020046793/0001564590-20-046793-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1008848/000156459020050001/0001564590-20-050001-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1008848/000156459020051662/0001564590-20-051662-index.htm |
| 2020-01-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1008848/999999999520000160/9999999995-20-000160-index.htm |
| 2020-07-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1008848/999999999520001658/9999999995-20-001658-index.htm |
| 2020-09-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1008848/999999999520002494/9999999995-20-002494-index.htm |
| 2020-09-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1008848/999999999520002495/9999999995-20-002495-index.htm |
| 2019-08-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1008848/999999999719006446/9999999997-19-006446-index.htm |
| 2019-08-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1008848/999999999719006447/9999999997-19-006447-index.htm |
| 2019-08-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1008848/999999999719006450/9999999997-19-006450-index.htm |
| 2019-08-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1008848/999999999719006451/9999999997-19-006451-index.htm |
| 2020-05-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1008848/999999999720002714/9999999997-20-002714-index.htm |
| 2020-05-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1008848/999999999720002718/9999999997-20-002718-index.htm |
Acorda Therapeutics, Inc (ACOR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acorda Therapeutics, Inc (ACOR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 169%Institutional Ownership: 4959%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-22 | Jane Wasman | President, Intl and GC | Buy | 2,500.00 | 107,787.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064144/0001209191-18-064144-index.htm | ||
| 2019-12-02 | Jane Wasman | President, Intl and GC | Sell | 2,227.00 | 1.60 | 3,552.73 | 117,420.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058939/0001209191-19-058939-index.htm |
| 2019-03-08 | Jane Wasman | President, Intl and GC | Buy | 12,813.00 | 119,647.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018799/0001209191-19-018799-index.htm | ||
| 2019-12-02 | Lauren M Sabella | Chief Commercial Officer | Sell | 1,513.00 | 1.60 | 2,421.10 | 12,624.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058938/0001209191-19-058938-index.htm |
| 2019-12-02 | DAVID LAWRENCE | Chief, Bus. Ops & PAO | Sell | 1,176.00 | 1.60 | 1,879.95 | 12,961.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058937/0001209191-19-058937-index.htm |
| 2019-03-08 | DAVID LAWRENCE | Chief, Bus. Ops & PAO | Buy | 9,045.00 | 14,137.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018794/0001209191-19-018794-index.htm | ||
| 2019-03-08 | Lauren M Sabella | Chief Commercial Officer | Buy | 9,045.00 | 14,137.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018797/0001209191-19-018797-index.htm | ||
| 2019-03-08 | Andrew A. Hindman | Chief Business Officer | Buy | 9,045.00 | 15,639.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018791/0001209191-19-018791-index.htm | ||
| 2020-09-17 | Lauren M Sabella | Chief Commercial Officer | Buy | 3,015.00 | 15,639.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051241/0001209191-20-051241-index.htm | ||
| 2020-09-17 | DAVID LAWRENCE | Chief, Bus. Ops & PAO | Buy | 3,015.00 | 15,976.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051240/0001209191-20-051240-index.htm | ||
| 2018-12-22 | BURKHARD BLANK | Chief Medical Officer | Buy | 2,100.00 | 32,350.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064139/0001209191-18-064139-index.htm | ||
| 2019-03-08 | BURKHARD BLANK | CMO and Head of R&D | Buy | 9,045.00 | 41,395.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018786/0001209191-19-018786-index.htm | ||
| 2020-09-17 | BURKHARD BLANK | CMO and Head of R&D | Buy | 3,015.00 | 44,410.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051237/0001209191-20-051237-index.htm | ||
| 2019-01-30 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 7,000.00 | 16.01 | 112,039.20 | 4,750,219.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319002315/0000899243-19-002315-index.htm |
| 2019-01-25 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 2,401.00 | 16.00 | 38,416.00 | 4,757,219.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319002030/0000899243-19-002030-index.htm |
| 2019-01-24 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 8,600.00 | 16.03 | 137,851.12 | 4,759,620.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319002030/0000899243-19-002030-index.htm |
| 2019-01-23 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 45,898.00 | 16.01 | 734,941.73 | 4,768,220.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001870/0000899243-19-001870-index.htm |
| 2019-01-22 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 51,945.00 | 16.02 | 831,971.90 | 4,814,118.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001870/0000899243-19-001870-index.htm |
| 2019-01-18 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 39,358.00 | 16.24 | 639,327.42 | 4,866,063.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001594/0000899243-19-001594-index.htm |
| 2019-01-17 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 100,000.00 | 16.86 | 1,685,550.00 | 4,905,421.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001594/0000899243-19-001594-index.htm |
| 2018-12-22 | RON COHEN | President and CEO | Buy | 5,980.00 | 493,534.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064140/0001209191-18-064140-index.htm | ||
| 2019-01-16 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 91,650.00 | 16.94 | 1,552,413.53 | 5,005,421.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001353/0000899243-19-001353-index.htm |
| 2019-02-22 | DAVID LAWRENCE | Chief, Bus. Ops & PAO | Sell | 761.00 | 13.18 | 10,028.31 | 5,092.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012973/0001209191-19-012973-index.htm |
| 2019-02-22 | Lauren M Sabella | Chief Commercial Officer | Sell | 761.00 | 13.18 | 10,028.23 | 5,092.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119012975/0001209191-19-012975-index.htm |
| 2019-01-15 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 1,700.00 | 16.60 | 28,223.06 | 5,097,071.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001353/0000899243-19-001353-index.htm |
| 2019-01-11 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 40,392.00 | 17.40 | 702,788.49 | 5,098,771.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001225/0000899243-19-001225-index.htm |
| 2019-01-10 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 87,491.00 | 17.29 | 1,512,728.14 | 5,139,163.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001035/0000899243-19-001035-index.htm |
| 2019-03-08 | RON COHEN | President and CEO | Buy | 25,629.00 | 517,136.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119018789/0001209191-19-018789-index.htm | ||
| 2019-01-09 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 75,000.00 | 17.05 | 1,278,705.00 | 5,226,654.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319001035/0000899243-19-001035-index.htm |
| 2019-01-08 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 59,174.00 | 16.24 | 960,926.59 | 5,301,654.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000841/0000899243-19-000841-index.htm |
| 2019-01-07 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 75,000.00 | 16.56 | 1,241,737.50 | 5,360,828.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000841/0000899243-19-000841-index.htm |
| 2019-01-04 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 31,591.00 | 16.61 | 524,713.87 | 5,435,828.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000662/0000899243-19-000662-index.htm |
| 2019-01-03 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 23,616.00 | 15.74 | 371,644.99 | 5,467,419.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000662/0000899243-19-000662-index.htm |
| 2018-12-28 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 52,891.00 | 14.99 | 792,751.46 | 5,491,035.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924319000110/0000899243-19-000110-index.htm |
| 2018-12-27 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 50,000.00 | 14.66 | 732,760.00 | 5,543,926.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031937/0000899243-18-031937-index.htm |
| 2018-12-26 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 50,000.00 | 14.66 | 732,820.00 | 5,593,926.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031937/0000899243-18-031937-index.htm |
| 2018-12-21 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 40,506.00 | 13.24 | 536,096.91 | 5,643,926.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031705/0000899243-18-031705-index.htm |
| 2018-12-20 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 40,000.00 | 14.03 | 561,368.00 | 5,684,432.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031586/0000899243-18-031586-index.htm |
| 2018-12-19 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 1,900.00 | 16.03 | 30,460.99 | 5,724,432.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031586/0000899243-18-031586-index.htm |
| 2018-12-19 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 3,100.00 | 15.87 | 49,202.89 | 5,726,332.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031586/0000899243-18-031586-index.htm |
| 2018-12-18 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 30,000.00 | 16.88 | 506,496.00 | 5,729,432.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031410/0000899243-18-031410-index.htm |
| 2018-12-18 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 50,000.00 | 16.97 | 848,445.00 | 5,759,432.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031410/0000899243-18-031410-index.htm |
| 2018-12-17 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 41,853.00 | 16.49 | 690,101.56 | 5,809,432.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031410/0000899243-18-031410-index.htm |
| 2018-12-14 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 28,796.00 | 16.15 | 464,977.65 | 5,851,285.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031240/0000899243-18-031240-index.htm |
| 2018-12-22 | DAVID LAWRENCE | Chief, Bus. Ops & PAO | Buy | 2,200.00 | 5,853.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064142/0001209191-18-064142-index.htm | ||
| 2018-12-22 | Lauren M Sabella | Chief Commercial Officer | Buy | 2,200.00 | 5,853.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064143/0001209191-18-064143-index.htm | ||
| 2018-12-13 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 33,061.00 | 16.27 | 537,760.31 | 5,880,081.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318031240/0000899243-18-031240-index.htm |
| 2018-12-12 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 100,000.00 | 16.30 | 1,629,790.00 | 5,913,142.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318030850/0000899243-18-030850-index.htm |
| 2018-12-11 | CAPITAL MANAGEMENT LP SCOPIA | 10% Share Holder | Sell | 200,000.00 | 16.30 | 3,259,500.00 | 6,013,142.00 | https://www.sec.gov/Archives/edgar/data/1008848/000089924318030850/0000899243-18-030850-index.htm |
| 2019-12-02 | RON COHEN | President and CEO | Sell | 4,699.00 | 1.60 | 7,505.24 | 607,287.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919119058936/0001209191-19-058936-index.htm |
| 2020-09-17 | RON COHEN | President and CEO | Buy | 8,543.00 | 640,980.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919120051239/0001209191-20-051239-index.htm | ||
| 2018-12-22 | Andrew A. Hindman | Chief Business Officer | Buy | 2,300.00 | 7,471.00 | https://www.sec.gov/Archives/edgar/data/1008848/000120919118064141/0001209191-18-064141-index.htm |